| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00268-012-1472-9 |
| P8608 | Fatcat ID | release_tgce3bfb4rf7hgpjiay6fufbxm |
| P698 | PubMed publication ID | 22374538 |
| P50 | author | Kwhanmien Kim | Q112185527 |
| P2093 | author name string | Jhingook Kim | |
| Hong Kwan Kim | |||
| Yong Soo Choi | |||
| Young Mog Shim | |||
| Jong Ho Cho | |||
| P2860 | cites work | Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial | Q28377003 |
| Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial | Q35532111 | ||
| Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study | Q36614079 | ||
| Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided | Q37576267 | ||
| The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours | Q39512984 | ||
| Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer? | Q40255270 | ||
| Are bilobectomies acceptable procedures? | Q40484071 | ||
| Operative complications and early mortality after induction therapy for lung cancer | Q43430653 | ||
| A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). | Q44310150 | ||
| Analyses on prognostic factors following tri-modality therapy for stage IIIa non-small cell lung cancer | Q44512311 | ||
| Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer | Q44557538 | ||
| A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer | Q45232525 | ||
| Risk factors for early mortality and morbidity after pneumonectomy: a reappraisal. | Q46791870 | ||
| Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. | Q51013426 | ||
| Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Onco | Q52943270 | ||
| Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. | Q53814690 | ||
| Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy | Q59566178 | ||
| The place for bilobectomy in bronchogenic carcinoma | Q67548822 | ||
| Bilobectomy for bronchogenic carcinoma | Q69815756 | ||
| Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients | Q70460340 | ||
| Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer | Q72134633 | ||
| Staging and resection of lung cancer with minimal invasion of the adjacent lobe | Q81439750 | ||
| Bilobectomy for non-small cell lung cancer: a search for clinical factors that may affect perioperative morbidity and long-term survival | Q84471950 | ||
| P433 | issue | 5 | |
| P921 | main subject | chemoradiotherapy | Q5090613 |
| P304 | page(s) | 1199-1205 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | World Journal of Surgery | Q15763279 |
| P1476 | title | Risk associated with bilobectomy after neoadjuvant concurrent chemoradiotherapy for stage IIIA-N2 non-small-cell lung cancer | |
| P478 | volume | 36 |
| Q40804974 | Bilobectomy for lung cancer: contemporary national early morbidity and mortality outcomes. |
| Q44300864 | Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery |
| Q37121347 | Prognostic factors in non-small cell lung cancer patients who received neoadjuvant therapy and curative resection. |
Search more.